Rivomox 400 mg filmom obložene tablete ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

rivomox 400 mg filmom obložene tablete

double-e pharma ltd., 7th floor, hume house, ballsbridge, dublin, irska - moksifloksacinklorid - filmom obložena tableta - 400 mg - urbroj: svaka filmom obložena tableta sadrži 400 mg moksifloksacina (u obliku klorida)

Rivoxin 400 mg filmom obložene tablete ক্রোয়েশিয়া - ক্রোয়েশীয় - HALMED (Agencija za lijekove i medicinske proizvode)

rivoxin 400 mg filmom obložene tablete

double-e pharma ltd., 17 corrig road, sandyford, irska - moksifloksacinklorid - filmom obložena tableta - 400 mg - urbroj: svaka filmom obložena tableta sadrži 400 mg moksifloksacina (u obliku moksifloksacinklorida)

TRUSOPT 2% Kapi za oči, rastvor মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

trusopt 2% kapi za oči, rastvor

"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-podgorica - dorzolamid - kapi za oči, rastvor - 2%

COSOPT 2%+0.5% Kapi za oči, rastvor মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

cosopt 2%+0.5% kapi za oči, rastvor

"glosarij" druŠtvo sa ograniČenom odgovornoŠĆu za trgovinu, grafiČku djelatnost, proizvodnju i usluge-cetinje - timolol, dorzolamid - kapi za oči, rastvor - 2%+0.5%

COSOPT BEZ KONZERVANSA 2% + 0.5% Kapi za oči, rastvor মন্টিনিগ্রো - ক্রোয়েশীয় - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

cosopt bez konzervansa 2% + 0.5% kapi za oči, rastvor

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - timolol, dorzolamid - kapi za oči, rastvor - 2% + 0.5%

Lonsurf ইউরোপীয় ইউনিয়ন - ক্রোয়েশীয় - EMA (European Medicines Agency)

lonsurf

les laboratoires servier - trifluridine, tipiracil hidroklorid - kolorektalne neoplazme - antineoplastična sredstva - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.